おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Tau Consortium
company
About
Tau Consortium’s mission is to accelerate the development of new treatments for Alzheimer’s disease.
Highlights
Details
- Industries
- Health Care,Non Profit
- Founded date
- Jan 1, 2009
- Operating Status
- Active
Tau Consortium is a collaborative research program that is managed and funded by the Rainwater Charitable Foundation in partnership with other funders.They commission world-class research and drug discovery to treat and prevent primary tauopathies like progressive supranuclear palsy, as well as secondary ones such as Alzheimer’s disease. They strategy is to engage and support talented researchers.
Investments
Number of Investments
Number of Lead Investments
1
0
Tau Consortium has made 1 investments. Their most recent investment was on
Jan 17, 2019, when Aquinnah Pharmaceuticals raised $750K.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 17, 2019
Aquinnah Pharmaceuticals
|
Grant | $750K | Health Care | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
